Journal of International Oncology››2017,Vol. 44››Issue (7): 490-495.doi:10.3760/cma.j.issn.1673-422X.2017.07.003
Previous ArticlesNext Articles
He Qihua
Received:
2017-01-19Online:
2017-07-08Published:
2017-06-20Contact:
He Qihua E-mail:nyzhangpeihua@163.comHe Qihua. Effect and mechanism of microRNA24 on cell proliferation and migration of osteosarcoma cell line U2OS[J]. Journal of International Oncology, 2017, 44(7): 490-495.
[1] Osasan S, Zhang M, Shen F, et al. Osteogenic sarcoma: a 21st century review[J]. Anticancer Res, 2016, 36(9): 4391-4398. DOI: 10.21873/anticanres.10982. [2] Gutowski CJ, BasuMallick A, Abraham JA. Management of bone sarcoma[J]. Surg Clin North Am, 2016, 96(5): 1077-1106. DOI: 10.1016/j.suc.2016.06.002. [3] MarioEnríquez A, Bovée JV. Molecular pathogenesis and diagnostic, prognostic and predictive molecular markers in sarcoma[J]. Surg Pathol Clin, 2016, 9(3): 457-473. DOI: 10.1016/j.path.2016.04.009. [4] Fuentes E, Palomo I, Alarcón M. Platelet miRNAs and cardiovascular diseases[J]. Life Sci, 2015, 133: 2944. DOI: 10.1016/j.lfs.2015.04.016. [5] MomenHeravi F, Trachtenberg AJ, Kuo WP, et al. Genomewide study of salivary microRNAs for detection of oral cancer[J]. J Dent Res, 2014, 93 Suppl 7: S86-S93. DOI: 10.1177/0022034514531018. [6] Fang Z, Tang J, Bai Y, et al. Plasma levels of microRNA24, microRNA320a, and microRNA4235p are potential biomarkers for colorectal carcinoma[J]. J Exp Clin Cancer Res, 2015, 34: 86. DOI: 10.1186/s13046-015-0198-6. [7] Lu K, Wang J, Song Y, et al. miRNA243p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1[J]. Oncol Rep, 2015, 34(2): 995-1002. DOI: 10.3892/or.2015.4025. [8] Lin SC, Liu CJ, Lin JA, et al. miR24 upregulation in oral carcinoma: positive association from clinical and in vitro analysis[J]. Oral Oncol, 2010, 46(3): 204-208. DOI: 10.1016/j.oraloncology.2009.12.005. [9] Zhao G, Liu L, Zhao T, et al. Upregulation of miR24 promotes cell proliferation by targeting NAIF1 in nonsmall cell lung cancer[J]. Tumour Biol, 2015, 36(5): 3693-3701. DOI: 10.1007/s1327701430084. [10] Inoguchi S, Seki N, Chiyomaru T, et al. Tumoursuppressive microRNA241 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer[J]. FEBS Lett, 2014, 588(17): 3170-3179. DOI: 10.1016/j.febslet.2014.06.058. [11] Zhang MX, Zhang J, Zhang H, et al. miR243p suppresses malignant behavior of lacrimal adenoid cystic carcinoma by targeting PRKCH to regulate p53/p21 pathway[J]. PLoS One, 2016, 11(6): e0158433. DOI: 10.1371/journal.pone.0158433. [12] Song L, Yang J, Duan P, et al. MicroRNA24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ[J]. Arch Biochem Biophys, 2013, 535(2): 128-135. DOI: 10.1016/j.abb.2013.04.001. [13] Tang H, Massi D, Hemmings BA, et al. AKTions with a TWIST between EMT and MET[J]. Oncotarget, 2016, 7(38): 62767-62777. DOI: 10.18632/oncotarget.11232. [14] Klbl AC, Jeschke U, Andergassen U. The significance of epithelialtomesenchymal transition for circulating tumor cells[J]. Int J Mol Sci, 2016, 17(8): pii: E1308. DOI: 10.3390/ijms17081308. [15] Choi BH, Lee DH, Kim J, et al. Controls of nuclear factorkappa B signaling activity by 5′AMPactivated protein kinase activation with examples in human bladder cancer cells[J]. Int Neurourol J, 2016, 20(3): 182-187. DOI: 10.5213/inj.1632718.359. [16] Matthews GM, de Matos Simoes R, Dhimolea E, et al. NF-κB dysregulation in multiple myeloma[J]. Semin Cancer Biol, 2016, 39: 68-76. DOI: 10.1016/j.semcancer.2016.08.005. [17] Gao S, Sun Y, Zhang X, et al. IGFBP2 activates the NF-κB pathway to drive epithelialmesenchymal transition and invasive character in pancreatic ductal adenocarcinoma[J]. Cancer Res, 2016, 76(22): 6543-6554. DOI: 10.1158/00085472.CAN160438. [18] Wang X, Liu Y, Dai L, et al. Foxp3 downregulation in NSCLC mediates epithelialmesenchymal transition via NFκB signaling[J]. Oncol Rep, 2016, 36(4): 2282-2288. DOI: 10.3892/or.2016.5024. |
[1] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[2] | Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311. |
[3] | Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao.Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma[J]. Journal of International Oncology, 2024, 51(4): 239-244. |
[4] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[5] | Ma Xiaoping, Chang Junli, Sun Xingyuan, Yang Yanping.Study progression on mechanism of long non-coding RNAs regulating drug resistance in osteosarcoma[J]. Journal of International Oncology, 2023, 50(1): 51-54. |
[6] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
[7] | Shi Yu, Chen Xi, Xu Mengqi, Zhang Yingying, Ji Honghai, Jiang Yingying.Effects of PSIP1 gene silencing on migration and invasion of oral squamous cell carcinoma cells[J]. Journal of International Oncology, 2022, 49(3): 129-133. |
[8] | Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua.Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells[J]. Journal of International Oncology, 2022, 49(2): 73-78. |
[9] | Wang Ziyi, Chen Hongjie, Yang Ninggang, Zhang Jun, Zhang Xiangjun, Yu Xinning, Ma Zhongyi, Dai Enlai.Effects of decorin on proliferation, migration and invasion of bladder cancer cells[J]. Journal of International Oncology, 2021, 48(6): 335-340. |
[10] | Li Bingliang, Yang Ya, Huang Yingli, Si Wen, Li Xingwei, Zhang Yuanmin, Bian Jichao, Chen Yu.Effects of miR-20a-5p targeting KDM6B on the proliferation, migration and invasion of osteosarcoma cells[J]. Journal of International Oncology, 2021, 48(2): 65-73. |
[11] | Zhao Lili, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhang Xue, Jing Wenjun, Wei Hongmei.Effects of silencing PD-L1 expression on biological behaviors of gastric cancer cells[J]. Journal of International Oncology, 2021, 48(12): 705-710. |
[12] | Xiong Lin, Zhang Xiuyun, Zhang Xiaoyu, Li Yue, Xu Ximing.IWR-1-endo affects the migration and proliferation of hepatocarcinoma cells by inhibiting the Wnt pathway[J]. Journal of International Oncology, 2021, 48(12): 711-715. |
[13] | Li Zhefeng, Li Jie, Zhao Xiaoting, Yue Wentao.GLDC regulates proliferation and apoptosis of ovarian cancer cells through PI3K/Akt/mTOR pathway[J]. Journal of International Oncology, 2021, 48(12): 716-722. |
[14] | Yang Xiao1, Li Si2, Peng Jin3, Wang Lin4, Wu Yilun4, Feng Ying2.Effect of plasma membrane-associated sialidase NEU3 activity on the proliferation and apoptosis of osteosarcoma MG-63 cells[J]. Journal of International Oncology, 2019, 46(4): 193-198. |
[15] | Liu Wenbin, Gao Nina.Clinical significance of miR-210 expression in breast cancer tissues and its influence on malignant behavior of triple negative breast cancer cells[J]. Journal of International Oncology, 2018, 45(8): 525-530. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||